Mayo Clinic Laboratories, founded in 1971, serves as the global reference laboratory for the renowned Mayo Clinic. This entity garners attention for its pivotal role in enhancing patient care through an expansive range of specialized testing services, backed by collaborations with clinicians both at Mayo Clinic and around the world.
Known for its sophisticated test catalog, Mayo Clinic Laboratories executes approximately 24 million tests annually. Its extensive network of over 4,500 physicians and scientists, as well as more than 90 subspecialty pathologists, underscores its significant impact, as does its contribution of 560 peer-reviewed articles each year.
Despite the absence of recent investment details, the foundational partnership with Mayo Clinic ensures sustained innovation and leadership in the diagnostics industry. With a global patient base of 4.5 million, this company stands out as an attractive opportunity for investors seeking to engage with a leader in healthcare diagnostics.